NASDAQ: EPIXEssa Pharma Inc Stock Ownership - Who owns Essa Pharma?
Insider buying vs selling
Have Essa Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Growth N. V. Biotech | 10% Owner | 2024-11-01 | 2,000,000 | $1.53 | $3.06MSell |
| Growth N. V. Biotech | 10% Owner | 2024-11-01 | 2,000,000 | $1.53 | $3.06MSell |
| Growth N. V. Biotech | 10% Owner | 2024-11-01 | 2,000,000 | $1.53 | $3.05MSell |
| Growth N. V. Biotech | 10% Owner | 2024-11-01 | 1,879,583 | $1.51 | $2.84MSell |
| Peter Virsik | Chief Operating Officer | 2024-10-07 | 694 | $6.03 | $4.18kSell |
| Peter Virsik | Chief Operating Officer | 2024-09-09 | 694 | $6.00 | $4.16kSell |
| Peter Virsik | Chief Operating Officer | 2024-09-03 | 2,082 | $6.03 | $12.55kSell |
EPIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EPIX insiders and whales buy or sell their stock.
EPIX Shareholders
What type of owners hold Essa Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bvf Inc | 19.71% | 8,748,629 | $14.96M | Institution |
| Tang Capital Management LLC | 9.69% | 4,300,000 | $7.35M | Institution |
| Morgan Stanley | 9.69% | 4,299,768 | $7.35M | Institution |
| Bml Capital Management LLC | 9.51% | 4,221,546 | $7.22M | Institution |
| Clarus Lifesciences III LP | 8.05% | 3,573,053 | $6.11M | Insider |
| Soleus Capital Management LP | 5.10% | 2,262,026 | $3.87M | Institution |
| Opaleye Management Inc | 4.98% | 2,209,998 | $3.78M | Institution |
| Pfizer Inc | 3.77% | 1,675,000 | $2.86M | Institution |
| Altium Capital Management LLC | 2.37% | 1,050,369 | $1.80M | Institution |
| Franklin M. Berger | 1.77% | 784,404 | $1.34M | Insider |
EPIX vs Biotech Stocks
Essa Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.